SURVIVAL ANALYSIS OF TIME TO FIRST ADVERSE DRUG REACTION AND DRUG SURVIVAL IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH METHOTREXATE AND HYDROXYCHLOROQUINE MONOTHERAPIES OR COMBINATION THERAPY

被引:0
|
作者
Velthuis, K. [1 ]
Nguyen, M. [1 ]
Scholl, J. [1 ]
Jansen, J. [1 ]
Van Lint, J. [1 ]
Ten Klooster, P. [2 ,3 ]
Vonkeman, H. [3 ,4 ]
Jessurun, N. [1 ]
机构
[1] Netherlands Pharmacovigilance Ctr Lareb, Res Dept, sHertogenbosch, Netherlands
[2] Transparency Healthcare BV, Hengelo, Netherlands
[3] Univ Twente, Dept Psychol Hlth & Technol, Enschede, Netherlands
[4] Medisch Spectrum Twente, Dept Rheumatol & Clin Immunol, Enschede, Netherlands
关键词
D O I
10.1136/annrheumdis-2021-eular.181
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
POS0648
引用
收藏
页码:562 / 563
页数:2
相关论文
共 50 条
  • [41] Drug survival of leflunomide for treatment of patients with rheumatoid arthritis in daily clinical practice
    Kievit, W
    Welsing, PMJ
    Franssen, J
    van Riel, PLCM
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 464 - 464
  • [42] Low Persistence Rates in Patients With Rheumatoid Arthritis Treated With Triple Therapy and Adverse Drug Events Associated With Sulfasalazine
    Erhardt, Daniel P.
    Cannon, Grant W.
    Teng, Chia-Chen
    Mikuls, Ted R.
    Curtis, Jeffrey R.
    Sauer, Brian C.
    ARTHRITIS CARE & RESEARCH, 2019, 71 (10) : 1326 - 1335
  • [43] Is background methotrexate advantageous in extending TNF inhibitor drug survival in elderly patients with rheumatoid arthritis? An analysis of the British Society for Rheumatology Biologics Register
    Bechman, Katie
    Oke, Anuoluwapo
    Yates, Mark
    Norton, Sam
    Dennison, Elaine
    Cope, Andrew P.
    Galloway, James B.
    RHEUMATOLOGY, 2020, 59 (09) : 2563 - 2571
  • [44] Delayed Onset of Hepatitis and/or Neutropenia in Patients with Rheumatoid Arthritis Treated with Combination Therapy of Methotrexate and Leflunomide
    Choi, Seung Won
    Oh, Ji Seon
    Kim, You Jae
    Koo, Bon San
    So, Min Wook
    Kim, Yong-Gil
    Lee, Chang-Keun
    Yoo, Bin
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S153 - S154
  • [45] Usefulness of three-drug additional combination therapy with bucillamine, sulfasalazine and methotrexate for refractory rheumatoid arthritis
    Hamada, Y
    Shinomiya, F
    Okada, M
    Fujimura, T
    INTERNATIONAL JOURNAL OF IMMUNOTHERAPY, 2002, 18 (02): : 57 - 64
  • [46] DRUG SURVIVAL OF GOLIMUMAB IN JAPANESE PATIENTS WITH RHEUMATOID ARTHRITIS IS INDEPENDENT OF METHOTREXATE AND PREDNISOLONE CONCOMITANCE: RESULTS FROM THE MULTICENTER BIOLOGICS REGISTRY
    Hayashi, M.
    Kanamono, T.
    Matsubara, H.
    Kishimoto, K.
    Takahashi, N.
    Kojima, T.
    Ishiguro, N.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 235 - 235
  • [47] DRUG SURVIVAL AND REASONS FOR DISCONTINUATION OF THE FIRST COURSE OF BIOLOGICAL THERAPY IN 363 JUVENILE IDIOPATHIC ARTHRITIS PATIENTS
    Romano, M.
    Pontikaki, I.
    Ardoino, I.
    Gattinara, M.
    Del Giudice, E.
    Boracchi, P.
    Rizzini, S. Lodi
    Meroni, P. L.
    Gerloni, V.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 585 - 586
  • [48] DRUG SURVIVAL AND REASONS FOR DISCONTINUATION OF THE FIRST COURSE OF BIOLOGICAL THERAPY IN 301 JUVENILE IDIOPATHIC ARTHRITIS PATIENTS
    Romano, M.
    Pontikaki, I.
    Gattinara, M.
    Ardoino, I.
    Donati, C.
    Boracchi, P.
    Meroni, P. L.
    Gerloni, V.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 266 - 266
  • [49] Drug survival and reasons for discontinuation of the first course of biological therapy in 301 juvenile idiopathic arthritis patients
    Romano, M.
    Pontikaki, I.
    Gattinara, M.
    Ardoino, I.
    Donati, C.
    Boracchi, P.
    Meroni, P. L.
    Gerloni, V.
    REUMATISMO, 2013, 65 (06) : 278 - 285
  • [50] Shortening of the lag time to first disease modifying antirheumatic drug therapy in rheumatoid arthritis patients in Spain
    Clemente, D.
    Abasolo, L.
    Loza, E.
    Lopez-Gonzalez, R.
    Vadillo, C.
    Fernandez-Gutierrez, B.
    Morado, I.
    Judez, E.
    Rodriguez, L.
    Jover, J.
    Hernandez-Garcia, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 164 - 164